Abstract:ObjectiveThe mortality rate of lung cancer ranks first in malignant tumors. Among them, non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer patients. In this study, we explore part of the mechanism of development and progression of NSCLC.Methods/ ResultsFirstly, there was an increase in microRNA-221-3p (miR-221-3p) expression and a decrease in Axin2 expression in NSCLC tissues using real-time reverse transcription polymerase chain reaction. Further studies showed that miR-221-3p inhibited the expression of Axin2, which negatively regulated the Wnt signaling pathway. With the method of inhibiting and overexpressing the expression of miR-221-3p and/or Axin2 respectively in NSCLC cell lines A549 and H1975, we found that inhibiting the expression of miR-221-3p leaded to a decrease in cell proliferation, migration and invasion, just like the results of overexpressing Axin2. Relatively speaking, overexpression of miR-221-3P in NSCLC cell lines showed the increase of proliferation as well as the decrease of apoptosis. Thus, we knew that miR-221-3p promoted the migration and invasion of NSCLC cells in vitro. What’s more, according to western blot and EdU assay, we demonstrated that overexpression of miR-221-3p inhibited the expression of Axin2 and subsequently activate classical Wnt/β-catenin signaling pathway. At last, a series of methods were used to identify that miR-221-3p inhibited Axin2 expression, increased cell proliferation, invasion and migration, and decreased cell apoptosis.ConclusionOur results suggest that miR-221-3p inhibits the expression of Axin2 and indirectly activates the typical Wnt/β-catenin signaling pathway, thus promoting tumor proliferation and invasion in NSCLC.

The roles of AXIN2 in tumorigenesis and epigenetic regulation

The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility

Mechanism of Tumorigenesis Regulated by Axin

Genetic and Epigenetic Regulation of E-Cadherin Signaling in Human Hepatocellular Carcinoma.

Regulation of Epigenetics on Cell Cycle Progression and Expression of Tumor-Associated Genes in Human Colon Cancer Cells

Canonical Wnt Suppressor, Axin2, Promotes Colon Carcinoma Oncogenic Activity

Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements

Regulation Of Epithelial Branching Morphogenesis And Cancer Cell Growth Of The Prostate By Wnt Signaling

The Role and Epigenetic Regulation of the CDX Gene Family in Human Cancer

The Expression and Methylation of AXIN2 Gene in Hepatocellular Carcinoma

XRN2 Promotes EMT and Metastasis Through Regulating Maturation of Mir-10A.

Crucial Role of Anxa2 in Cancer Progression: Highlights on Its Novel Regulatory Mechanism

The Role of Non-Coding RNA in Tumorigenesis, Development,diagnosis and Treatment

Roles of Axin in the Wnt Signaling Pathway

Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential

The regulation of β-catenin activity and function in cancer: therapeutic opportunities

AXIN2 is a non‐redundant regulator of AXIN1 stability and β‐catenin in colorectal cancer cells

Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network

MicroRNA-221-3p promotes proliferation and invasion in non-small cell lung cancer via targeting Axin2 to regulate Wnt/β-catenin signaling pathway

CBX2 and EZH2 Cooperatively Promote the Growth and Metastasis of Lung Adenocarcinoma